Search for Clinical Trial Results
Inappropriate ADH Syndrome - 16 Studies Found
Status | Study |
Completed |
Study Name: Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion Condition:
Date: 2005-12-12 Interventions: Drug: SR121463B |
Completed |
Study Name: Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion Condition:
Date: 2005-12-12 Interventions: Drug: SR121463B |
Completed |
Study Name: Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study Condition: Inappropriate ADH Syndrome Date: 2016-03-24 Interventions:
|
Withdrawn |
Study Name: Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine Condition: Syndrome of Inappropriate ADH-secretion Date: 2006-03-01 Interventions: Procedure: fluid restriction for 14 days (15ml fluid per kg weight) |
Terminated |
Study Name: A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia Condition:
Date: 2008-07-31 Interventions:
|
Completed |
Study Name: A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Condition: Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Date: 2013-12-09 Interventions: Drug: tolvaptan Subjects will receive a single dose of 3.75, 7.5 or 15 mg of tolvaptan on study Day 1 |
Completed |
Study Name: Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion Condition:
|
Recruiting |
Study Name: A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH Condition: Syndrome of Inappropriate Antidiuretic Hormone Secretion Date: 2017-02-07 Interventions: Drug: Tolvaptan Oral Tablet Tolvaptan tablets at 7.5, 15, 30 (one tablet each), or 60 mg (two 30 mg tabl |
Terminated |
Study Name: Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia Condition:
|
Completed |
Study Name: An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain Condition:
|